Published in Proc Natl Acad Sci U S A on February 01, 1978
Detection of a transformation-related antigen in chemically induced sarcomas and other transformed cells of the mouse. Proc Natl Acad Sci U S A (1979) 6.93
Tumor rejection antigens of chemically induced sarcomas of inbred mice. Proc Natl Acad Sci U S A (1986) 2.94
Regression and inhibition of sarcoma growth by interference with a radiosensitive T-cell population. J Exp Med (1978) 1.46
Identification of a unique tumor antigen as rejection antigen by molecular cloning and gene transfer. J Exp Med (1986) 1.27
Definition of a unique cell surface antigen of mouse leukemia RL male 1 by cell-mediated cytotoxicity. Proc Natl Acad Sci U S A (1979) 1.13
Tumor-enhancing suppressor activator T cells in spleens and thymuses of tumor immune mice. Proc Natl Acad Sci U S A (1979) 0.96
Regulation of immune responses against the syngeneic ADJ-PC-5 plasmacytoma in BALB/c mice. I. Analysis of immune parameters involved. Immunology (1981) 0.83
Detection of polymorphism in BALB/c leukemia viruses with mouse antisera. J Virol (1979) 0.81
Isolation and characterization of a tumor cell surface antigen from spontaneously transformed BALB/c mouse fibroblasts. Proc Natl Acad Sci U S A (1978) 0.77
RNA-dependent DNA polymerase in virions of Rous sarcoma virus. Nature (1970) 19.89
RNA-dependent DNA polymerase in virions of RNA tumour viruses. Nature (1970) 19.38
Immunity to methylcholanthrene-induced sarcomas. J Natl Cancer Inst (1957) 10.10
Cell membrane antigen isolation with the staphylococcal protein A-antibody adsorbent. J Immunol (1976) 7.63
Serologically defined and lymphocyte-defined components of the major histocompatibility complex in the mouse. J Exp Med (1972) 4.59
Qualitative and quantitative studies of AKR-type murine leukemia virus sequences in mouse DNA. Cold Spring Harb Symp Quant Biol (1975) 4.49
Differential function of major histocompatibility complex antigens in T-lymphocyte activation. Nature (1976) 3.87
Endogenous oncornaviral gene expression in adult and fetal mice: quantitative, histologic, and physiologic studies of the major viral glycorprotein, gp70. J Exp Med (1976) 3.51
Radioimmunoassay of mammalian type C viral proteins. I. Species specific reactions of murine and feline viruses. J Immunol (1972) 3.23
Characterization of murine leukaemia virus-specific DNA present in normal mouse cells. Nat New Biol (1973) 2.98
Autogenous immunity to endogenous RNA tumor virus. Radioimmune precipitation assay of mouse serum antibody levels. J Exp Med (1973) 2.31
Distribution of three classes of endogenous type-C RNA viruses among inbred strains of mice. Virology (1975) 2.07
Search for common antigenicities among twenty-five sarcomas induced by methylcholanthrene. Cancer Res (1970) 1.73
In vitro studies of immune reactions against autochthonous and syngeneic mouse tumors induced by methylcholanthrene and plastic discs. Int J Cancer (1968) 1.73
Prevalence of the group-specific (gs) antigen and infectious virus expressions of the murine C-type RNA viruses during the life span of BALB-cCr mice. Int J Cancer (1972) 1.70
Serologic approaches to the study of cancer in animals and in man. Cancer Res (1968) 1.65
Expression of murine leukemia virus structural antigens on the surface of chemically induced murine sarcomas. Proc Natl Acad Sci U S A (1974) 1.54
H-2 gene complex and its role in alloimmune reactions. Transplant Rev (1973) 1.36
A microassay for antibody binding to tumor cell surface antigens using 125I-labelled protein a from Staphylococcus aureus. J Immunol Methods (1977) 1.36
Immune response in the mouse to endogenous leukemia viruses. Cold Spring Harb Symp Quant Biol (1975) 1.22
RNA tumor-virus antigen expression in chemically induced tumors. Virus-genome-specified common antigens detected by complement fixation in mouse tumors induced by 3-methylcholanthrene. J Natl Cancer Inst (1971) 1.10
Genetic control of the expression of murine leukemia virus proteins in tissues of normal, young adult mice. Cold Spring Harb Symp Quant Biol (1975) 1.07
Natural immunity in mice to structural polypeptides of endogenous type C RNA viruses. J Virol (1976) 1.06
Serum mediated inhibition of cellular immunity to methylcholanthrene-induced murine sarcomas. Cell Immunol (1970) 1.02
Cross-reacting antigens in chemically induced sarcomas are fetal determinants. J Immunol (1977) 0.95
Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science (1998) 17.91
The current and future market for veterinarians and veterinary medical services in the United States. J Am Vet Med Assoc (1999) 9.90
Monoclonal antibodies to Chlamydia trachomatis: antibody specificities and antigen characterization. J Immunol (1982) 8.61
Finding protein similarities with nucleotide sequence databases. Methods Enzymol (1990) 6.63
Culture-independent diagnosis of Chlamydia trachomatis using monoclonal antibodies. N Engl J Med (1984) 6.08
Serological classification of Neisseria gonorrhoeae with monoclonal antibodies. Infect Immun (1982) 5.54
Serological classification of Neisseria gonorrhoeae with use of monoclonal antibodies to gonococcal outer membrane protein I. J Infect Dis (1984) 5.40
Suggestive evidence that the "blocking antibodies" of tumor-bearing individuals may be antigen--antibody complexes. Proc Natl Acad Sci U S A (1971) 5.38
A proposed nomenclature for the virion proteins of oncogenic RNA viruses. Virology (1974) 5.01
The isolation of hybrid cell lines producing monoclonal antibodies against the p15(E) protein of ecotropic murine leukemia viruses. Virology (1979) 4.59
Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group. N Engl J Med (1998) 4.38
Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4. Cell (1992) 4.34
Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors. Nat Med (1997) 3.89
Canadian normative data for the SF-36 health survey. Canadian Multicentre Osteoporosis Study Research Group. CMAJ (2000) 3.77
Cellular immunity against tumor antigens. Adv Cancer Res (1969) 3.70
The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha2delta subunit of a calcium channel. J Biol Chem (1996) 3.26
Detection of avian and mammalian oncogenic RNA viruses (oncornaviruses) by immunofluorescence. Cancer Res (1972) 3.23
Monoclonal antibodies to cytomegalovirus: rapid identification of clinical isolates and preliminary use in diagnosis of cytomegalovirus pneumonia. Infect Immun (1982) 3.22
Abrogation of cellular immunity to antigenically foreign mouse embryonic cells by a serum factor. Nature (1969) 3.20
Immunological enhancement as studied by cell culture techniques. Annu Rev Microbiol (1970) 3.12
Identification of a human T lymphocyte surface protein associated with the E-rosette receptor. J Exp Med (1981) 3.06
Blocking of cell-mediated tumor immunity by sera from patients with growing neoplasms. Int J Cancer (1971) 3.06
Demonstration of cell-mediated immunity to human neoplasms of various histological types. Int J Cancer (1971) 2.88
Soluble member(s) of the mesothelin/megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma. Proc Natl Acad Sci U S A (1999) 2.87
Serum bone Gla-protein: a specific marker for bone formation in postmenopausal osteoporosis. Lancet (1984) 2.85
Chromatographic separation and antigenic analysis of proteins of the oncornaviruses. II. Mammalian leukemia-sarcoma viruses. J Virol (1972) 2.84
Studies on cellular immunity and its serum mediated inhibition in Moloney-virus-induced mouse sarcomas. Int J Cancer (1969) 2.80
Evaluation of decision rules for referring women for bone densitometry by dual-energy x-ray absorptiometry. JAMA (2001) 2.70
Lymphocyte-mediated cytotoxicity and blocking serum activity to tumor antigens. Adv Immunol (1974) 2.68
Monoclonal antibodies against murine leukemia viruses: identification of six antigenic determinants on the p 15(E) and gp70 envelope proteins. Virology (1979) 2.62
Monoclonal antibodies to herpes simplex viruses: use in antigenic typing and rapid diagnosis. J Infect Dis (1983) 2.60
Typing of clinical herpes simplex virus isolates with mouse monoclonal antibodies to herpes simplex virus types 1 and 2: comparison with type-specific rabbit antisera and restriction endonuclease analysis of viral DNA. J Clin Microbiol (1983) 2.50
Transcription of mouse mammary tumor virus genes in tissues from high and low tumor incidence mouse strains. J Mol Biol (1973) 2.45
Cellular and humoral immunity to different types of human neoplasms. Nature (1968) 2.40
Cell surface antigens of human melanoma identified by monoclonal antibody. Proc Natl Acad Sci U S A (1979) 2.40
The influence of osteoporotic fractures on health-related quality of life in community-dwelling men and women across Canada. Osteoporos Int (2001) 2.32
Oncogenicity of AKR endogenous leukemia viruses. J Virol (1978) 2.31
Serum-mediated protection of neoplastic cells from inhibition by lymphocytes immune to their tumor-specific antigens. Proc Natl Acad Sci U S A (1969) 2.28
Group-specific viral antigens in the milk and tissues of mice naturally infected with mammary tumor virus or Gross leukemia virus. Virology (1968) 2.26
Phosphorylation of synthetic peptides by a tyrosine protein kinase from the particulate fraction of a lymphoma cell line. Proc Natl Acad Sci U S A (1982) 2.25
Common properties of the oncogenic RNA viruses (oncornaviruses). Virology (1970) 2.20
Vaccinia virus encodes a polypeptide homologous to epidermal growth factor and transforming growth factor. Nature (1985) 2.15
Identification of a cell surface protein, p97, in human melanomas and certain other neoplasms. Proc Natl Acad Sci U S A (1980) 2.14
A summary of mechanistic hypotheses of gabapentin pharmacology. Epilepsy Res (1998) 2.12
Demonstration of cell-bound and humoral immunity against neuroblastoma cells. Proc Natl Acad Sci U S A (1968) 2.12
Selective inactivation of the transacylase components of the 2-oxo acid dehydrogenase multienzyme complexes of Escherichia coli. Biochem J (1976) 2.10
Monoclonal antibodies for diagnosis of infectious diseases in humans. Science (1983) 2.02
Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity. J Exp Med (1994) 1.93
Antibody to leukemia virus: widespread occurrence in inbred mice. Science (1974) 1.91
A review of the genetic effects of naturally occurring flavonoids, anthraquinones and related compounds. Mutat Res (1980) 1.89
Mammary tumour virus specific nucleotide sequences in mouse DNA. Nat New Biol (1972) 1.87
Endogenous ecotropic mouse type C viruses deficient in replication and production of XC plaques. J Virol (1976) 1.87
The impact of incident fractures on health-related quality of life: 5 years of data from the Canadian Multicentre Osteoporosis Study. Osteoporos Int (2008) 1.86
Characterization of monoclonal antibodies to Treponema pallidum. J Immunol (1985) 1.83
The x-ray structure of an anti-tumour antibody in complex with antigen. Nat Struct Biol (1995) 1.76
Elution of "blocking factors" from human tumors, capable of abrogating tumor-cell destruction by specifically immune lymphocytes. Int J Cancer (1972) 1.76
Serological analysis of the deoxyribonucleic acid polymerase of avian oncornaviruses. II. Comparison of avian deoxyribonucleic acid polymerases. J Virol (1972) 1.75
Monoclonal mouse antibodies raised against human lung carcinoma. Cancer Res (1986) 1.75
In vitro studies of immune reactions against autochthonous and syngeneic mouse tumors induced by methylcholanthrene and plastic discs. Int J Cancer (1968) 1.73
Oncornaviruses produced by murine leukemia cells in culture. Virology (1977) 1.73
Topological mapping of murine leukemia virus proteins by competition-binding assays with monoclonal antibodies. Virology (1980) 1.72
Quantitative analysis of melanoma-associated antigen p97 in normal and neoplastic tissues. Proc Natl Acad Sci U S A (1981) 1.70
Immunological tolerance: "forbidden clones" allowed in tetraparental mice. Proc Natl Acad Sci U S A (1971) 1.67
The care gap in diagnosis and treatment of women with a fragility fracture. Osteoporos Int (2007) 1.64
Chimeric mouse-human IgG1 antibody that can mediate lysis of cancer cells. Proc Natl Acad Sci U S A (1987) 1.61
Viral proteins expressed on the surface of murine leukemia cells. J Virol (1977) 1.60
Oral leukoplakia status six weeks after cessation of smokeless tobacco use. J Am Dent Assoc (1999) 1.58
Costimulation of T cells for tumor immunity. Immunol Today (1993) 1.57
Highly tumor-reactive, internalizing, mouse monoclonal antibodies to Le(y)-related cell surface antigens. Cancer Res (1990) 1.57
Molecular cloning of the human B cell CD20 receptor predicts a hydrophobic protein with multiple transmembrane domains. EMBO J (1988) 1.57
Cellular immunity and its serum-mediated inhibition in Shope-virus-induced rabbit papillomas. Int J Cancer (1969) 1.56
Endogenous oncornaviruses in chemically induced transformation. I. Transformation independent of virus production. Virology (1975) 1.55
Identification of the Gross cell surface antigen associated with murine leukemia virus-infected cells. J Virol (1977) 1.54